How could you not when you grow up hearing inspiring stories about your strong and courageous grandmother who diagnosed herself with breast cancer while in medical school?
Unfortunately, her grandmother’s breast cancer metastasized to the spine and she passed away at the young age of 29. This great loss inspired Priscilla to pursue a career in cancer research.
While in medical school, Priscilla’s mom was diagnosed with metastatic breast cancer in her 40s. The difficult journey of the surgeries, chemotherapy and radiation began, creating trepidation and fear. “As the disease progressed, I threw myself into metastatic research to try to discover ways to help my mom,” she recalls. Sadly, her mom passed away. “While I lost the race against her illness, I’m still fighting for all the other patients that have metastatic cancer.”
These personal experiences fuel Dr. Brastianos’ dedication to keep searching for answers to help the 200,000-300,000 people diagnosed with metastatic brain cancer each year.
Before she died, my mom said she wanted me to find better treatment options. So, that’s what really drives me every day, knowing that I’m doing what I promised her I would do.
An oncologist working at Massachusetts General Hospital, Dr. Brastianos not only cares for patients with metastatic disease, but she also aggressively pursues brain metastasis research.
As a former recipient of the American Brain Tumor Association’s research grant program, Dr. Brastianos is now collaborating with the ABTA to explore the unmet needs of patients and caregivers impacted by metastatic disease. The ABTA’s Metastatic Brain Tumor Initiative seeks to better understand the needs of medical professionals, as well as patients and caregivers. The ABTA aims to use these insights to address gaps across patient education and support.
Through the generous support of donors, the ABTA’s grant program continues to support researchers to pursue brain tumor research. With more than $32 million invested in brain tumor research, the ABTA is dedicated to ensuring researchers have the resources they need to fight this unforgiving disease.